FLGT
Fulgent Genetics IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$441.32M
P/E Ratio
—
EPS
$-1.97
Beta
0.89
52W High
$31.04
52W Low
$13.46
50-Day MA
$16.78
200-Day MA
$22.24
Dividend Yield
—
Profit Margin
-18.80%
Forward P/E
7.70
PEG Ratio
1.32
About Fulgent Genetics Inc
Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. The company is headquartered in Temple City, California.
Fundamentals
| Revenue (TTM) | $322.67M |
| Gross Profit (TTM) | $130.88M |
| EBITDA | $-65.05M |
| Operating Margin | -41.20% |
| Return on Equity | -5.51% |
| Return on Assets | -4.58% |
| Revenue/Share (TTM) | $10.48 |
| Book Value | $35.78 |
| Price-to-Book | 0.40 |
| Price-to-Sales (TTM) | 1.37 |
| EV/Revenue | 0.35 |
| EV/EBITDA | 2.34 |
| Quarterly Earnings Growth (YoY) | -98.60% |
| Quarterly Revenue Growth (YoY) | 9.30% |
| Shares Outstanding | $28.84M |
| Float | $19.68M |
| % Insiders | 35.01% |
| % Institutions | 62.19% |
Analyst Ratings
Consensus ($26.00 target)
1
Strong Buy1
Buy1
HoldData last updated: 4/29/2026